Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
Although checkpoint blockade temporarily improves exhausted CD8 T (T<sub>ex</sub>) cell function, the underlying T<sub>ex</sub> epigenetic landscape remains largely unchanged, preventing durable T<sub>ex</sub> "reinvigoration" in cancer and chronic infections. The transcription factor TOX initiates T<sub>ex</sub> epigenetic programming, yet it remains unclear whether TOX continually preserves T<sub>ex</sub> biology after T<sub>ex</sub> establishment. Here, we demonstrated that induced TOX ablation in committed T<sub>ex</sub> cells resulted in apoptotic-driven loss of T<sub>ex</sub> cells, reduced expression of inhibitory receptors, and decreased terminal differentiation. Gene expression and epigenetic profiling revealed a critical role for TOX in maintaining chromatin accessibility and transcriptional patterns in committed T<sub>ex</sub> cells. Moreover, TOX removal endows established T<sub>ex</sub> cells with greater fate flexibility to differentiate into more functional effector-like T cells. Thus, continuous TOX expression in established T<sub>ex</sub> cells acts as a durable epigenetic barrier reinforcing the T<sub>ex</sub> developmental fate. TOX manipulation even after T<sub>ex</sub> establishment could therefore provide therapeutic opportunities to rewire T<sub>ex</sub> cells in chronic infections or cancer.
Authors
- Jennifer E. Wu (ORCID: https://orcid.org/0000-0002-9302-8904)
- Omar Khan (ORCID: https://orcid.org/0000-0002-7641-6163)
- Yinghui Huang
- Shin Foong Ngiow (ORCID: https://orcid.org/0000-0002-5738-2834)
- E. John Wherry (ORCID: https://orcid.org/0000-0003-0477-1956)
- Simone L. Park (ORCID: https://orcid.org/0000-0003-1507-0864)
- Josephine R. Giles (ORCID: https://orcid.org/0000-0002-3713-338X)
- Amy E. Baxter (ORCID: https://orcid.org/0000-0002-1555-0713)
- Sasikanth Manne (ORCID: https://orcid.org/0000-0001-9856-0871)
Institutions
- Parker Institute for Cancer Immunotherapy (US)
- Translational Therapeutics (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Science Immunology
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1126/sciimmunol.ado3032
- Citations
- 24
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 25.09